Lumigan vs Addyi: side-by-side comparison
Lumigan (Ophtalmologie et traitements oculaires) and Addyi (Santé sexuelle féminine) belong to different therapeutic classes and are rarely interchangeable. This page compares the medications' purposes, mechanisms and the situations where each is used.
| Property | Lumigan | Addyi |
|---|---|---|
| Active ingredient | Bimatoprost | Flibanserin |
| Manufacturer | AbbVie / Allergan | Sprout Pharmaceuticals |
| Class | Ophtalmologie et traitements oculaires | Santé sexuelle féminine |
| Strengths | 0.01%, 0.03% | 100mg |
| Forms | ophthalmic solution | tablet |
What's the same
Lumigan and Addyi are used in very different patients, and the points in common are limited. The main shared element is that both meet regulatory standards for efficacy and safety and benefit from pharmacist oversight.
Key differences
Lumigan belongs to Ophtalmologie et traitements oculaires while Addyi belongs to Santé sexuelle féminine. Indications, mechanisms and target populations differ. The comparison is most useful when a clinician has mentioned both medications and the patient wants to understand where each fits.
Mechanism and action
Lumigan: Le bimatoprost est un analogue des prostamides qui augmente l'écoulement de l'humeur aqueuse par le trabéculum et par la voie uvéosclérale, abaissant la pression intraoculaire. Addyi: Le désir sexuel est modulé par des voies complexes du système nerveux central impliquant la sérotonine (globalement inhibitrice) ainsi que la dopamine et la noradrénaline (globalement excitatrices).
When Lumigan is preferred
Lumigan est autorisé chez l'adulte dans la réduction de la pression intraoculaire élevée en cas de glaucome chronique à angle ouvert ou d'hypertonie oculaire.
When Addyi is preferred
Addyi est indiqué dans le traitement du trouble du désir sexuel hypoactif acquis et généralisé chez la femme non ménopausée, dans les pays où il est autorisé.
Questions fréquentes
Is Lumigan or Addyi better? ▾
Lumigan and Addyi are not interchangeable — they treat different conditions. Asking which is "better" is meaningful only when a clinician has weighed both for the same specific clinical scenario.
Can I switch from Lumigan to Addyi? ▾
Switching between Lumigan and Addyi is rarely an appropriate decision since they belong to different classes and treat different conditions. The real question is usually whether the diagnosis calls for one medication or the other — which the prescriber resolves.
Do Lumigan and Addyi have the same side effects? ▾
No — they belong to different classes and have distinct side-effect profiles. Each medication has its own prescribing information.
More Lumigan comparisons
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.